Department of Emergency and Critical Care Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinkjuku, Tokyo, 164-8582, Japan.
Department of Surgery, Saiseikai Utsunomiya Hospital, Tochigi, Japan.
World J Emerg Surg. 2021 May 27;16(1):27. doi: 10.1186/s13017-021-00374-z.
The effect of antithrombotic drugs on intraoperative operative blood loss volume in patients undergoing emergency surgery for generalized peritonitis is not well defined. The purpose of this study was to investigate the effect of antithrombotic drugs on intraoperative blood loss in patients with generalized peritonitis using a nationwide surgical registry in Japan.
This retrospective cohort study used a nationwide surgical registry data from 2011 to 2017 in Japan. Propensity score matching for the use of antithrombotic drugs was used for the adjustment of age, gender, comorbidities, frailty, preoperative state, types of surgery, surgical approach, laboratory data, and others. The main outcome was intraoperative blood loss: comparison of intraoperative blood loss, ratio of intraoperative blood loss after adjusted for confounding factors, and variable importance of all covariates.
A total of 70,105 of the eligible 75,666 patients were included in this study, and 2947 patients were taking antithrombotic drugs. Propensity score matching yielded 2864 well-balanced pairs. The blood loss volume was slightly higher in the antithrombotic drug group (100 [10-349] vs 70 [10-299] ml). After adjustment for confounding factors, the use of antithrombotic drugs was related to a 1.30-fold increase in intraoperative blood loss compared to non-use of antithrombotic drugs (95% CI, 1.16-1.45). The variable importance revealed that the effect of the use of antithrombotic drugs was minimal compared with surgical approach or type of surgery.
This study shows that while taking antithrombotic drugs is associated with a slight increase in intraoperative blood loss in patients undergoing emergency surgery for generalized peritonitis, the effect is likely of minimal clinical significance.
抗血栓药物对接受全身腹膜炎急诊手术患者术中失血量的影响尚未明确。本研究旨在使用日本全国外科登记处调查抗血栓药物对全身腹膜炎患者术中失血的影响。
本回顾性队列研究使用了日本 2011 年至 2017 年全国外科登记处的数据。采用倾向评分匹配法比较抗血栓药物的使用情况,调整年龄、性别、合并症、虚弱、术前状态、手术类型、手术入路、实验室数据等混杂因素。主要结局为术中失血量:比较调整混杂因素后的术中失血量、术中失血量比值以及所有协变量的重要性变量。
共纳入 75666 例符合条件的患者中的 70105 例,其中 2947 例患者正在服用抗血栓药物。采用倾向评分匹配法获得 2864 对均衡匹配。抗血栓药物组的失血量略高(100[10-349]ml 比 70[10-299]ml)。调整混杂因素后,与未使用抗血栓药物相比,使用抗血栓药物与术中失血增加 1.30 倍相关(95%CI,1.16-1.45)。重要性变量显示,与手术入路或手术类型相比,抗血栓药物的使用效果很小。
本研究表明,在接受全身腹膜炎急诊手术的患者中,使用抗血栓药物与术中失血量轻微增加相关,但可能具有最小的临床意义。